Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2025 ∙ Okoli, G. N. Grossman Moon, A. Soos, A. E. Neilson, C. J. Harper, D. M.

Hepatitis B vaccination initiation and vaccination series completion: An in-depth systematic evidence review, with meta-analysis of associations with individual socioeconomic and health-related factors

  • All age groups
  • Hepatitis B
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rivera-Izquierdo, M. Verdejo-Ianez, A. Morales-Portillo, A. Gonzalez-Alcaide, M. Lainez-Ramos-Bossini, A. J. Martinez-Ruiz, V. Fernandez-Martinez, N. F. Martin-delosReyes, L. M. Jimenez-Mejias, E. Guerrero-Fernandez de Alba, I. Valero-Ubierna, M. D. C. Lardelli-Claret, P. Schoenenberger-Arnaiz, J. A. Jimenez-Moleon, J. J.

High-dose versus standard-dose influenza vaccine for immunocompromised patients: A systematic review and meta-analysis of randomised clinical trials

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Prokopovich, K. Braunack-Mayer, A. Phillipson, L.

How community engaged practices are applied in interventions promoting human papillomavirus (HPV) vaccination for culturally and linguistically diverse (CALD) children and adolescents: a systematic review

  • Adolescents
  • Parents/caregivers
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Renzi, E. Panattoni, N. Di Simone, E. Riccio, M. Conti, A. Albanesi, B. Luciani, M. Fabrizi, D. Locatelli, G. Ausili, D. Clari, M. De Vito, C. Massimi, A.

How should vaccine hesitancy be measured in healthcare workers? A systematic review of the measurement properties of validated tools

  • Healthcare workers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Hoang, T. N. A. Byrne, A. Quach, H. L. Bannister-Tyrrell, M. Vogt, F.

How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Montero-Macias, R. Adam, M. Rouzier, R. Bonneau, C.

HPV vaccination efficacy in primary and tertiary prevention of vulvar and vaginal HPV-related high grade dysplasia and cancers: A systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chan, K. S. K. Mak, T. S. T. Yu, O. Y. Lee, V. H. F. Chu, C. H. Chan, S. C. S. Choi, H. C. W.

HPV Vaccine Communication and Administration for the Prevention of Oropharyngeal Cancer in Dental Primary Care: Perspectives of Professionals and Students-A Systematic Review

  • All age groups
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ganesh, V. Iampietro, J. Sridhar, S. Goncalvez, A.

Human Immune Response to Influenza Neuraminidase After Vaccination: A Systematic Review

  • All age groups
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mallon, M. Albraikat, M. Kunzmann, A. James, J. A. Craig, S. G.

Human papilloma virus genotypes associated with non-cervical HPV positive cancer development in UK and Ireland cohorts: a systematic review

  • Europe
  • United Kingdom
  • Ireland
  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bergman, H. Henschke, N. Arevalo-Rodriguez, I. Buckley, B. S. Crosbie, E. J. Davies, J. C. Dwan, K. Golder, S. P. Loke, Y. K. Probyn, K. et al.,

Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV‐related diseases: a network meta‐analysis

  • All age groups
  • Pregnant women
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
Loading...